Navigation Links
Mirixa Corporation Announces MirixaEdge(SM)
Date:10/19/2009

NEW ORLEANS, Oct. 19 /PRNewswire/ -- NCPA 111th Annual Convention -- Mirixa Corporation, the leader in targeted pharmacy-based patient care services, has announced the launch of MirixaEdge(SM). Previewed to independent pharmacists at the National Community Pharmacists Association's annual convention, MirixaEdge enables pharmacists to design their own patient care programs for any of their patients regardless of health plan, employer, or age.

MirixaEdge capitalizes on the nation's leading web-based clinical platform, MirixaPro(SM), which is available to over 40,000 contracted pharmacies nationwide to identify patient health care issues, highlight potential medication-related interactions, and encourage standardized care by pharmacists. MirixaEdge helps jumpstart the process of personalized program creation by providing pharmacists with pre-defined templates for conditions such as diabetes, asthma, and cardiovascular disease. Pharmacists can also take advantage of a template for medication therapy management. Additional MirixaEdge templates are planned.

"MirixaEdge helps pharmacists improve health outcomes for their patients, drive down health care costs and provide greater access to care," said Rick Solano, Mirixa's Chief Executive Officer. "The product expands patient care opportunities for community pharmacy and enables pharmacists to proactively engage their patients in the kind of dialogue that drives customer loyalty and trust."

MirixaEdge provides pharmacies with a standardized platform on which to establish their unique pharmacy patient care programs, capture outcomes measurements, and use that information to educate patients about their health issues.

A select group of MirixaPro participating pharmacies have participated in beta testing of MirixaEdge. One member of the pilot group, Justin Wilson, PharmD., of Valu-Med Pharmacy in Midwest City, OK, anticipates that using MirixaEdge will enhance customer relations and notes, "This tool will provide our pharmacy with a mechanism to proactively engage patients in a dialogue about their medication. By initiating a discussion, our pharmacists will be better able to advise and educate the patient while at the same time encouraging them to adhere to their medication regime and to focus on healthy lifestyle choices."

About Mirixa

Mirixa Corporation, sponsored by the National Community Pharmacists Association (NCPA), is the leader in targeted patient care services delivered via the nation's largest pharmacy-based patient care network. Dedicated to improving patients' health, Mirixa enables the health care community to deliver patient care services through retail pharmacy. The MirixaPro(SM) web-based clinical platform is used by pharmacists to deliver standardized patient care services. For more information, please visit www.Mirixa.com.

    Contact:     Anne Marie Heil
                 610-933-8065 (o)
                 484-886-7540 (c)
                 amheil@amheil.com

SOURCE Mirixa Corporation


'/>"/>
SOURCE Mirixa Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Mirixa Corporation Announces Key Pharmacy Network Hire
2. WebMD and HLTH Corporation to Webcast Annual Meetings of Stockholders
3. Baxa Corporation Signs Exclusive Distribution Agreement With Leading Pharmaceutical Corporation in Peoples Republic of China
4. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
5. Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference
6. CEL-SCI Corporation Releases Letter to Shareholders
7. ETEX Corporation Announces Additional FDA Clearance For EquivaBone(R), The First Hard Setting Osteoconductive and Osteoinductive Bone Graft Substitute.
8. Clinical Logistics Enters Partnership with Gentris Corporation
9. Exsulin Corporation Announces Next Phase II Trial of Novel Islet Regeneration Treatment in Type 1 Diabetes
10. Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting on the Primary Treatment of Early Breast Cancer
11. Celladon Corporation Announces Presentation of First-in-Human Gene Transfer to Treat Heart Failure at the 12th Annual Meeting of the American Society of Gene Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)...  AllianceRx Walgreens Prime, the combined central specialty pharmacy ... benefit manager Prime Therapeutics LLC (Prime), today officially began ... unveiling of new signage at its headquarters in ... a few other company-owned facilities across the country. This ... of whom will begin to see the AllianceRx Walgreens ...
(Date:10/2/2017)... COPENHAGEN, Denmark , Oct. 2, 2017 The ... tool in the struggle to reverse the tide of prescription ... plan for regulating their medicine intake and stepping down their ... is set to launch in December 2017; the first 100,000 ... access. Learn more at http://www.rebound-solution.com/ ...
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans ... advance the use of wearable and home sensors for ... disorders. Early Signal Foundation, a nonprofit organization focused on ... will provide an affordable analytical system to record and ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... Del. (PRWEB) , ... October 12, 2017 , ... ... and advisory services for healthcare compliance program management, will showcase a range of ... National Association for Assisted Living (NCAL) Convention and Expo to be held October ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
Breaking Medicine News(10 mins):